Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView

Markets

Trending Stocks
Hot Crypto
News
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. EW
stocks logo

EW Valuation

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)

EW Relative Valuation

EW's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EW is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
Median5y
0.00
FCF Yield
Median3y
Median5y

People Also Watch

FAQ

arrow icon

Is Edwards Lifesciences Corp (EW) currently overvalued or undervalued?

Edwards Lifesciences Corp (EW) is now in the Fair zone, suggesting that its current forward PE ratio of NaN is considered Fairly compared with the five-year average of . The fair price of Edwards Lifesciences Corp (EW) is between to according to relative valuation methord.
arrow icon

What is Edwards Lifesciences Corp (EW) fair value?

EW's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Edwards Lifesciences Corp (EW) is between to according to relative valuation methord.
arrow icon

How does EW's valuation metrics compare to the industry average?

The average P/S ratio for EW's competitors is 5.21, providing a benchmark for relative valuation. Edwards Lifesciences Corp Corp (EW) exhibits a P/S ratio of 7.20, which is 38.27% above the industry average. Given its robust revenue growth of 9.43%, this premium appears unsustainable.
arrow icon

What is the current P/B ratio for Edwards Lifesciences Corp (EW) as of Apr 22 2025?

As of Apr 22 2025, Edwards Lifesciences Corp (EW) has a P/B ratio of . This indicates that the market values EW at times its book value.
arrow icon

What is the current FCF Yield for Edwards Lifesciences Corp (EW) as of Apr 22 2025?

As of Apr 22 2025, Edwards Lifesciences Corp (EW) has a FCF Yield of %. This means that for every dollar of Edwards Lifesciences Corp’s market capitalization, the company generates cents in free cash flow.
arrow icon

What is the current Forward P/E ratio for Edwards Lifesciences Corp (EW) as of Apr 22 2025?

As of Apr 22 2025, Edwards Lifesciences Corp (EW) has a Forward P/E ratio of . This means the market is willing to pay $ for every dollar of Edwards Lifesciences Corp’s expected earnings over the next 12 months.
arrow icon

What is the current Forward P/S ratio for Edwards Lifesciences Corp (EW) as of Apr 22 2025?

As of Apr 22 2025, Edwards Lifesciences Corp (EW) has a Forward P/S ratio of . This means the market is valuing EW at $ for every dollar of expected revenue over the next 12 months.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingView
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free